Skip to the main content.

Cannabinoid Analysis in Cannabis

ACCURATE CANNABINOID ANALYSIS FOR SAFER, COMPLIANT PRODUCTS

Contact us

 

CONSISTENCY THAT PATIENTS CAN COUNT ON

Medicinal cannabis plays a vital role in treating conditions like epilepsy, MS, and chronic pain. Patients and prescribers need assurance that cannabinoid levels are accurate, reliable, and repeatable. But achieving this consistency across batches and product types isn’t always straightforward.

For labs, that means having a robust analytical system that works across oils, tinctures, and more with confidence in every result.

 

Depositphotos_603728076_S

A DIFFERENT APPROACH TO POTENCY TESTING

Traditional profiling methods can be inconsistent or overly complex. The 200 Series GC system, when used with a liquid autosampler, offers a streamlined, reproducible method that simplifies potency testing.

This setup supports cannabis testing labs by reducing variability, increasing throughput, and meeting the traceability standards expected in medicinal markets.

Contact us

 

 

DESIGNED FOR RELIABLE CANNABINOID QUANTIFICATION

Our 200 Series GC provides fast, accurate separation and quantification of key cannabinoids, including THC, THCA, CBD, and CBDA. The method delivers clean chromatographic resolution with minimal operator input.

What to expect:

  • Reliable results across a range of cannabis matrices

  • Resolution of acidic vs. neutral cannabinoids

  • Compact, low maintenance platform

  • Method validated for medicinal use and regulatory reporting

200_Series_Dimensions
 

WORKS ACROSS REAL-WORLD SAMPLES

From dried flower to full spectrum oils and distillates, the method is designed to adapt to real-world testing demands. Our application note outlines retention times for 11 cannabinoids, plus example chromatograms and settings.

Includes:

  • Ellution-compatible method files

  • Runtime under 25 minutes

  • Support for UK MHRA and global GMP compliance

  • Simple integration with manual or autosampler workflows

Depositphotos_79413848_S

ABOUT US

At Ellutia, we know the importance of precision in medicinal cannabis testing. Inaccurate potency risks patient safety and can lead to regulatory issues. That’s why we build tools designed for the real challenges of today’s labs fast, scalable, and easy to use.

We’ve helped pharmaceutical manufacturers, cannabis producers, and regulatory labs implement compliant cannabinoid testing workflows now we’re here to help you.

READY TO DISCUSS YOUR CANNABIS TESTING NEEDS?

Get in touch

Tell us about your testing requirements.

 

Contact us

 

We’ll recommend the right setup


Our experts match you with the best GC system and method.

 

Start testing with confidence


Accurate results, made simple.

 

 

 

Visit our blog posts

3 min read

NDMA Contamination in Metformin: Detection, Risks, and Best Practices

The issue of NDMA contamination in pharmaceuticals like metformin has become an industry-wide focus due to its...
2 min read

Benefits of a Nitrosamine Selective Detector

Nitrosamines, such as N-Nitrosodimethylamine (NDMA), are carcinogenic compounds that can form during the drug...
2 min read

Nitrites and Nitrates: Understanding the Differences, Risks, and Solutions

Knowing the difference between nitrites and nitrates is key to addressing the challenges they present in...

MISSED OUR WEBINAR? DETECTING UNEXPECTED NITROSAMINE CONTAMINATION

One of the biggest challenges in nitrosamine analysis is identifying contaminants you’re not expecting. Standard testing methods like GC or LC can detect known nitrosamines but only if you have the right reference standards. Unexpected nitrosamines, however, can easily go unnoticed.

In this webinar, we explore practical analytical strategies that can help uncover potential nitrosamine contaminants even when specific standards aren't available. If your current methods rely heavily on predefined targets, this session will highlight ways to reduce risk and gain a clearer picture of contamination.

INTERESTED IN IMPROVING YOUR TESTING STRATEGY OR WANT ACCESS TO THE RECORDING?

Access the webinar